NGEF and colorectal carcinoma: Expression levels of pS16/S18 Ephexin1 were associated with increasingly malignant grades of CRC and LC and metastatic cancer, and high pS16/S18 Ephexin1 expression correlated with poor prognosis in CRC and LC patients.